Does Medicaid cover Ozempic or Wegovy?

It depends on your state. Medicaid is a joint federal-state program, and each state sets its own drug formulary within federal minimum requirements. Most states cover Ozempic (semaglutide for type 2 diabetes) because it's FDA-approved for a condition Medicaid must cover. Wegovy (semaglutide for weight management) coverage is more variable — some states have explicitly added it to their formulary, while others exclude anti-obesity medications entirely. Always check your state Medicaid program's preferred drug list or call member services.

Does Medicaid have to cover weight-loss drugs?

No. Unlike Medicare, Medicaid is not federally prohibited from covering weight-loss drugs — but it is not federally required to cover them either. States have broad discretion over their drug formularies. As of 2026, some states have voluntarily added Wegovy and Zepbound to their Medicaid formularies, recognizing obesity as a chronic disease. Others have not. The result is significant geographic inequity in access for Medicaid beneficiaries.

Can I use a manufacturer savings card with Medicaid?

No. The same federal Anti-Kickback Statute prohibition that bars Medicare beneficiaries from using manufacturer savings cards also applies to Medicaid beneficiaries. Pharmaceutical manufacturer coupons and savings cards cannot legally be used by patients whose medications are covered by any federal healthcare program including Medicare and Medicaid. Attempting to use these cards while on Medicaid could constitute a federal violation.

What if my state Medicaid doesn't cover GLP-1 medications for weight loss?

Options include: (1) If you have type 2 diabetes, your state may still cover the diabetes-indication drug (Ozempic/Mounjaro) even if it doesn't cover the weight-management versions. (2) Apply for a patient assistance program from Lilly or Novo Nordisk — these are designed to be compatible with Medicaid beneficiary eligibility requirements. (3) Contact your state Medicaid program or state legislature to advocate for expanded formulary coverage. (4) Ask your provider whether any clinical trial enrollment could provide access to GLP-1 medications at no cost.

Medicaid Guide · Updated May 2026

Medicaid Coverage for GLP-1 Medications by State (2026)

May 2026 | BetterNewLives.com

Unlike Medicare — which has a uniform federal prohibition on covering weight-loss drugs — Medicaid is a joint federal-state program where each state controls its own drug formulary. The result is significant variation: some states have added Wegovy and Zepbound to their Medicaid formularies, while others cover only diabetes-indication GLP-1 medications, and some states restrict coverage further with strict prior authorization requirements.

This guide maps the landscape as of May 2026. Coverage decisions change frequently — check your state program's preferred drug list for the most current status.

⚠️ Manufacturer savings cards cannot be used with Medicaid The federal Anti-Kickback Statute prohibits pharmaceutical manufacturers from offering coupons or savings cards to beneficiaries of any federal healthcare program, including Medicaid. Do not attempt to use a Lilly or Novo Nordisk savings card if your medications are covered by Medicaid — this could constitute a federal violation.

How Medicaid GLP-1 Coverage Works: The Framework

Federal law establishes minimum required drug coverage for state Medicaid programs. Within that floor, states have broad discretion to:

Restrict coverage to specific indications (e.g., diabetes only, not weight management)
Require prior authorization for certain drugs
Maintain preferred drug lists (PDL) that favor certain brands over others
Impose step therapy requirements (try Drug A before Drug B is covered)
Limit the duration of coverage or require periodic reauthorization

The key distinction that most affects GLP-1 access:

Diabetes indication coverage — Ozempic and Mounjaro prescribed for type 2 diabetes are typically covered, as diabetes is a standard Medicaid-covered condition
Weight-management indication coverage — Wegovy and Zepbound prescribed for obesity management are optional for states to cover; coverage is growing but still inconsistent

State-by-State Coverage Reference (2026)

📋 How to read this table "Diabetes coverage" refers to Ozempic/Mounjaro when prescribed for type 2 diabetes. "Weight-loss coverage" refers to Wegovy/Zepbound prescribed for chronic weight management. "With PA" means prior authorization is required. Coverage status is based on publicly available state formulary data as of May 2026 — verify directly with your state Medicaid program before relying on this information.

State	Diabetes-Indication GLP-1	Weight-Loss-Indication GLP-1	Prior Auth Required	Notes
Northeast
Connecticut	Covered	Covered	Yes	CT Medicaid added anti-obesity medications in 2024. PA required for weight-loss indication.
Maine	Covered	Limited	Yes	Weight-loss coverage available with prior auth and BMI ≥ 35 + comorbidity documentation.
Massachusetts	Covered	Covered	Yes	MassHealth covers anti-obesity medications with PA. Strong coverage history for metabolic conditions.
New Hampshire	Covered	Limited	Yes	Weight-loss coverage requires step therapy documentation (prior failed weight-loss interventions).
New Jersey	Covered	Covered	Yes	NJ FamilyCare added GLP-1 weight-loss coverage. PA requires BMI ≥ 30 + comorbidity or BMI ≥ 35.
New York	Covered	Covered	Yes	NY Medicaid covers GLP-1s for weight management with prior authorization. Robust appeals process.
Pennsylvania	Covered	Limited	Yes	PA Medical Assistance covers for diabetes. Weight-loss indication requires medical necessity documentation.
Vermont	Covered	Covered	Yes	Vermont Medicaid added weight-management drug coverage. PA with clinical criteria required.
Southeast
Alabama	Covered	Not covered	Yes (diabetes)	Anti-obesity medications are excluded from formulary. Diabetes-indication covered with PA.
Florida	Covered	Not covered	Yes (diabetes)	Florida Medicaid restricts to diabetes indication. Weight-management drugs not on formulary.
Georgia	Covered	Not covered	Yes	Georgia Medicaid does not cover anti-obesity medications as of 2026.
Kentucky	Covered	Under review	Yes	Kentucky Medicaid has been evaluating adding anti-obesity drug coverage. Status may change in 2026.
Louisiana	Covered	Not covered	Yes	Medicaid Healthy Louisiana covers diabetes-indication GLP-1. Weight-management excluded.
Maryland	Covered	Covered	Yes	Maryland Medicaid expanded coverage to anti-obesity medications in 2024. PA with BMI threshold required.
Mississippi	Covered	Not covered	Yes	Mississippi Medicaid does not cover anti-obesity medications. Diabetes indication covered with restrictions.
North Carolina	Covered	Limited	Yes	NC Medicaid Managed Care plans have variable coverage. Weight-loss drugs covered under some MCO contracts.
South Carolina	Covered	Not covered	Yes	Anti-obesity medications excluded. Diabetes-indication coverage available with prior auth.
Tennessee	Covered	Not covered	Yes	TennCare does not cover anti-obesity medications as of 2026.
Virginia	Covered	Covered	Yes	Virginia Medicaid expanded to cover anti-obesity medications in 2024. Requires BMI ≥ 30 + comorbidity or BMI ≥ 35.
West Virginia	Covered	Limited	Yes	WV Medicaid covers select anti-obesity drugs; coverage depends on specific MCO plan. Verify with your plan.
Midwest
Illinois	Covered	Covered	Yes	Illinois Medicaid expanded formulary to include Wegovy/Zepbound in 2024. BMI and clinical documentation required.
Indiana	Covered	Limited	Yes	Pathway HIP (Indiana Medicaid) covers some anti-obesity medications under specific programs. Varies by plan.
Iowa	Covered	Not covered	Yes	Iowa Medicaid does not include anti-obesity medications on its formulary as of 2026.
Michigan	Covered	Covered	Yes	Michigan Medicaid (MI Health Link) covers weight-management GLP-1s with prior authorization.
Minnesota	Covered	Covered	Yes	Minnesota Medical Assistance covers anti-obesity medications. PA requires documented clinical criteria.
Missouri	Covered	Not covered	Yes	MO HealthNet excludes anti-obesity medications. Diabetes-indication drugs covered with PA.
Ohio	Covered	Limited	Yes	Ohio Medicaid covers GLP-1s for diabetes; weight-loss coverage through some managed care plans only.
Wisconsin	Covered	Limited	Yes	BadgerCare covers GLP-1s for diabetes. Anti-obesity medication coverage is limited and requires PA.
Southwest & West
Arizona	Covered	Covered	Yes	AHCCCS expanded to cover anti-obesity medications. PA with BMI ≥ 30 + comorbidity documentation.
California	Covered	Covered	Yes	Medi-Cal covers weight-management GLP-1s with prior authorization. One of the stronger state programs for coverage.
Colorado	Covered	Covered	Yes	Colorado Medicaid added anti-obesity drug coverage in 2024. Clinical criteria apply.
Nevada	Covered	Limited	Yes	Nevada Medicaid covers diabetes-indication broadly. Weight-management coverage limited; check plan.
New Mexico	Covered	Covered	Yes	New Mexico Medicaid (Centennial Care) covers anti-obesity medications with PA.
Oregon	Covered	Covered	Yes	Oregon Health Plan covers weight-management GLP-1s. Requires BMI threshold and medical documentation.
Texas	Covered	Not covered	Yes	Texas Medicaid restricts GLP-1 coverage to diabetes indication. Anti-obesity medications excluded.
Washington	Covered	Covered	Yes	Apple Health (WA Medicaid) covers anti-obesity medications with PA. Good access in practice.
Mountain & Plains
Colorado	Covered	Covered	Yes	See above.
Idaho	Covered	Not covered	Yes	Idaho Medicaid does not cover anti-obesity medications as a standard benefit.
Montana	Covered	Limited	Yes	Montana Medicaid covers select anti-obesity medications under managed care. Varies by plan.
Utah	Covered	Not covered	Yes	Utah Medicaid does not include weight-management GLP-1s on formulary.
Wyoming	Covered	Not covered	Yes	Wyoming Medicaid (one of the smallest programs nationally) does not cover anti-obesity medications.

📍 Always verify directly with your state program This table reflects publicly available formulary information as of May 2026. Medicaid drug coverage is subject to change with each state legislative session, federal rulemaking, and managed care contract renewals. Always call your state Medicaid member services line or check your plan's online formulary lookup before drawing conclusions about your coverage. Formulary status can also vary between fee-for-service Medicaid and managed care organization (MCO) plans within the same state.

How to Check Your State's Current Coverage

Find your state Medicaid program's Preferred Drug List (PDL). Search "[Your State] Medicaid preferred drug list" or "[Your State] Medicaid formulary." Most states post their PDL online. Look for semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro, or Zepbound.
Call member services. The phone number is on your Medicaid card. Ask specifically: "Is [drug name] covered for [diabetes/weight management]? What documentation is required for prior authorization?"
If you're in a managed care plan, check with your MCO. Many states contract with private managed care organizations. Your plan's formulary may differ from the state's fee-for-service PDL. Your MCO's member handbook or website will have the formulary.
Ask your prescribing doctor's office. Experienced providers in your state will know from practice which GLP-1 medications are getting approved and what documentation makes the difference. This is often the fastest path to accurate information.
If denied, appeal. Medicaid denials are appealable. Request a written explanation of the denial and have your physician submit a medical necessity letter. If the internal appeal fails, you are entitled to a fair hearing with your state agency. Contact your State Health Insurance Assistance Program (SHIP) for free help navigating appeals.

What to Do If Your State Doesn't Cover Weight-Loss GLP-1s

If your state Medicaid program doesn't cover Wegovy or Zepbound for weight management, you have several paths:

1. The Diabetes Pathway

If you have type 2 diabetes or prediabetes with documented risk factors, your prescriber may be able to prescribe Ozempic or Mounjaro under the diabetes indication, which is covered in virtually all states. Discuss this with your provider — this is a legitimate clinical pathway if your diagnosis supports it.

2. Patient Assistance Programs

Lilly Cares Foundation and the Novo Nordisk Patient Assistance Program are legal for Medicaid beneficiaries (unlike savings cards). These programs provide free medication to qualifying patients based on income. Apply through your prescribing physician. Income thresholds are typically at or below 400% of the federal poverty level.

3. State Advocacy

Coverage decisions are made by state legislatures and Medicaid agencies — and they respond to constituent pressure. Contact your state representative and state health department. Organizations like the Obesity Action Coalition can help you engage in state-level advocacy effectively.

4. Check Your Eligibility for Marketplace Insurance

If your income has changed or you have a qualifying life event, you may be eligible to transition to an ACA Marketplace plan, which may have better GLP-1 coverage for your situation. Healthcare.gov has enrollment and eligibility information.

Related Resources

Cost Guide

Why GLP-1 Programs Cost So Much — and How to Pay Less

Savings Programs

Patient Assistance, Savings Cards & Free Medication Programs

Insurance Guide

How to Get Commercial Insurance to Cover GLP-1 Medications

Medicare Guide

GLP-1 Coverage Under Medicare: What's Allowed and What Isn't

Self-Pay Options

GLP-1 Options When You're Paying Out of Pocket

Interactive Tool

Find Your Best GLP-1 Option — Personalized Cost Estimator

This page provides general consumer reference information about state Medicaid drug coverage as of May 2026. Medicaid coverage is subject to change and varies by managed care plan within each state. This information is compiled from publicly available state formulary documents and is not a guarantee of coverage for any individual. Always verify your coverage directly with your state Medicaid program or managed care plan. This content does not constitute medical, legal, or benefits advice. Contact your State Health Insurance Assistance Program (SHIP) at 1-800-MEDICARE for free, personalized Medicare and Medicaid counseling.